Ofev (nintedanib)
pCPA File Number:
23083
Negotiation Status:
Active Negotiation
Indication(s):
Idiopathic pulmonary fibrosis and PF-ILD
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable